Evaluation of the Interplay between HIV and COVID-19 in a Large Urban Safety-net HIV Clinic
- Funded by University of California
- Total publications:0 publications
Grant search
Key facts
Disease
COVID-19Funder
University of CaliforniaPrincipal Investigator
Unspecified Monica GandhiResearch Location
United States of AmericaLead Research Institution
University of California-San FranciscoResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Prognostic factors for disease severity
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)
Vulnerable Population
Other
Occupations of Interest
Unspecified
Abstract
The COVID-19 pandemic has been moving quickly, including in areas of relatively high HIV prevalence, such as California. However, very little is known about how HIV and the virus that causes COVID-19 (SARS-CoV-2) interact, including whether HIV increases the risk of COVID-19; whether people with HIV develop long-lasting immunity against SARS-CoV-2 after infection; and whether the mandate to socially distance, keep patients with HIV away from clinics, and to provide care by telephone will make it more difficult for patients to take their antiretroviral therapy and maintain virologic suppression. This study in a large urban HIV clinic will look at whether people living with HIV get COVID-19 more easily and have worse clinical outcomes and will look at whether the public health measures and social distancing will influence clinical and other outcomes (like depression, anxiety, food insecurity, housing issues) among people with HIV.